Guidelines published by a government panel earlier this week, calling for aggressive use of statin medications to lower cholesterol in people at high risk of heart attacks, failed to list panelists' links to pharmaceutical companies, many of which manufacture statin drugs.
Of the nine panelists, six had received grants or consulting or speakers' fees from companies that produce some of the most popular statin medications on the market.
Newsday article
Of the nine panelists, six had received grants or consulting or speakers' fees from companies that produce some of the most popular statin medications on the market.
....but hey, do what you want....you will anyway.
No comments:
Post a Comment
Comments are moderated. There may be some delay before your comment is published. It all depends on how much time M has in the day. But please comment!